| Assessment Status | Assessment process complete |
| HTA ID | - |
| Drug | Glucosamine sulfate |
| Brand | Dona® |
| Indication | For the treatment of oestoarthritis in the Irish Healthcare setting. |
| Assessment Process | |
| Full pharmacoeconomic assessment commissioned by HSE | 04/05/2009 |
| NCPE assessment completed | 01/06/2009 |
| NCPE assessment outcome | Reimbursement not recommended. |